The UK Private GP EHR Market is expected to grow from 2023 to 2028 due to the increasing demand for private healthcare services and technological advancements in the medical sector, according to a report by ResearchAndMarkets. However, concerns about data security, and potential technical issues may hinder the market growth.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
